40
Participants
Start Date
February 1, 2022
Primary Completion Date
September 15, 2023
Study Completion Date
September 15, 2023
Oxytocin nasal spray
Intranasal treatment with oxytocin via nasal spray (48 IU per dose)
Placebo nasal spray
Intranasal treatment with placebo via nasal spray
Florida Institute for Human and Machine Cognition, Pensacola
University of Florida, Gainesville
Translational Genomics Research Institute, Phoenix
Office of Naval Research (ONR)
FED
University of Florida
OTHER
University of Alabama at Birmingham
OTHER
Translational Genomics Research Institute
OTHER
Florida Institute for Human and Machine Cognition
OTHER